Samsung BioLogics said JV partner Biogen to exercise option by late June
May 17, 2018 at 18:46 PM EDT
SEOUL, May 18 (Reuters) - Samsung BioLogics said on Friday that its joint venture partner Biogen would exercise its call option to increase its stake to 50 pct minus one share in Samsung Bioepis.
